BioLineRx BLRX
NASDAQ BLRX
$2.32 -0.04 (-1.69%)
As of: Sep 30, 2026 · 3:52 PM EDT

BioLineRx (BLRX) Accounts Payables (2010 - 2026)

Updated

BioLineRx (BLRX) recorded Accounts Payables of $4.29 million in the quarter ended Jun 30, 2026, up 23.9% from $3.47 million a year earlier but down 12.5% from the prior quarter.

Analysis

BioLineRx (BLRX) Accounts Payables (2010 - 2026) Analysis & Trends

As of Dec 31, 2025, BioLineRx reported Accounts Payables of $3.49 million, down 37.4% from the prior year.

  • Annual Accounts Payables has a five-year compound annual growth rate of -10.0% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Accounts Payables came in at $5.58 million in the year ended Dec 31, 2024 (-48.6%), $10.87 million in the year ended Dec 31, 2023 (+56.0%), $6.97 million in the year ended Dec 31, 2022 (+25.1%) and $5.57 million in the year ended Dec 31, 2021 (-5.9%).
  • Quarterly Accounts Payables has ranged from $3.47 million in the quarter ended Jun 30, 2025 to $10.87 million in the quarter ended Dec 31, 2023 over the past five years.
  • On a year-over-year basis, Accounts Payables rose in two of the last eight quarters, with an average decline of 26.8%.
  • Peak year-over-year performance for Accounts Payables in the last five years was growth of 56.0% in the quarter ended Dec 31, 2023, against a decline of 48.6% in the quarter ended Dec 31, 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.91 million (quarter ended Mar 31, 2026), $3.49 million (quarter ended Dec 31, 2025) and $3.54 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.22 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.30 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -22.89 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 429.50 Mn
10 BioLineRx 6.16 Bn 6.16 Bn 235,000.00 4.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.29 Mn
Mar 31, 2026 4.91 Mn
Dec 31, 2025 3.49 Mn
Sep 30, 2025 3.54 Mn
Jun 30, 2025 3.47 Mn
Mar 31, 2025 4.69 Mn
Dec 31, 2024 5.58 Mn
Sep 30, 2024 4.63 Mn
Jun 30, 2024 6.27 Mn
Mar 31, 2024 8.26 Mn
Dec 31, 2023 10.87 Mn
Sep 30, 2023 8.44 Mn
Jun 30, 2023 6.73 Mn
Mar 31, 2023 7.14 Mn
Dec 31, 2022 6.97 Mn
Sep 30, 2022 5.83 Mn
Jun 30, 2022 7.34 Mn
Mar 31, 2022 5.78 Mn
Dec 31, 2021 5.57 Mn
Sep 30, 2021 5.44 Mn
API Access

BioLineRx Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=BLRX&period=max&api_key=YOUR_API_KEY